Reduction of radiotherapy-induced late complications in early breast cancer: The role of intensity-modulated radiation therapy and partial breast irradiation. Part I - Normal tissue complications

Clinical Oncology

Volumn 17, Issue 1, 2005, Pages 16-24

  Coles, Charlotte E ^a   Moody, A M ^a   Wilson, C B ^a   Burnet, N G ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Late normal tissue complications; Radiotherapy

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; STEROID; TAMOXIFEN;

BREAST ATROPHY; BREAST CANCER; BREAST CARCINOMA; BREAST FIBROSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CARDIOTOXICITY; CLINICAL TRIAL; DOSIMETRY; DRUG MECHANISM; ESTHETICS; HUMAN; LUNG FIBROSIS; LUNG TOXICITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; REVIEW; RISK BENEFIT ANALYSIS; SKIN INDURATION;

ATROPHY; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FIBROSIS; HUMANS; MASTECTOMY, SEGMENTAL; MORBIDITY; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; TIME FACTORS;

EID: 11844284037     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.08.008     Document Type: Review

References (72)

1. H.J. Dobbs Radiation therapy for breast cancer at the millennium Radiother Oncol 54 2000 191-200
2. B. Fisher S. Anderson C.K. Redmond N. Wolmark D.L. Wickerham W.M. Cronin Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer N Engl J Med 333 1995 1456-1461
3. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group Lancet 355 2000 1757-1770
4. M. Overgaard P.S. Hansen J. Overgaard et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial N Engl J Med 337 1997 949-955
5. J. Ragaz S.M. Jackson N. Le et aL. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer N Engl J Med 337 1997 956-962
6. T.J. Whelan J. Julian J. Wright A.R. Jadad M.L. Levine Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis J Clin Oncol 18 2000 1220-1229
7. J. Van de Steene G. Soete G. Storme Adjuvant radiotherapy for breast cancer significantly improves overall survival: The missing link Radiother Oncol 55 2000 263-272
8. J. Cuzick H. Stewart R. Peto et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer Cancer Treat Rep 71 1987 15-29
9. A.P. Forrest H.J. Stewart D. Everington et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group Lancet 348 1996 708-713
10. G. Jabro D.E. Wazer R. Ruthazer et al. The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or =10 positive axillary nodes Int J Radiat Oncol Biol Phys 44 1999 273-280
11. B. Fisher J. Bryant J.J. Dignam et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less J Clin Oncol 20 2002 4141-4149
12. J.O. Archambeau R. Pezner T. Wasserman Pathophysiology of irradiated skin and breast Int J Radiat Oncol Biol Phys 31 1995 1171-1185
13. M.H. Barcellos-Hoff A role for transforming growth factor in radiation fibrosis U. Hagen D. Harder H. Jung C. Streffer Tenth international congress of radiation research 1995 761-764
14. START trial (standardisation of breast radiotherapy). A randomised comparison of fractionation regimens after local excision or mastectomy in women with early breast cancer; final protocol. In: UKCCR, 1998; http://212.219.75.236/ukcccr/text_only/home.html (last accessed 7 September 2004).
15. S.M. Bentzen H.D. Thames M. Overgaard Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study Radiother Oncol 15 1989 267-274
16. I. Turesson The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships Radiother Oncol 15 1989 217-226
17. S.M. Bentzen I. Turesson H.D. Thames Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: A graded-response analysis Radiother Oncol 18 1990 95-106
18. H.J. Sutherland G.A. Lockwood N.F. Boyd Ratings of the importance of quality of life variables: Therapeutic implications for patients with metastatic breast cancer J Clin Epidemiol 43 1990 661-666
19. S.K. Al-Ghazal R.W. Blamey J. Stewart A.A. Morgan The cosmetic outcome in early breast cancer treated with breast conservation Eur J Surg Oncol 25 1999 566-570
20. S.K. Al-Ghazal L. Fallowfield R.W. Blamey Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Oncol 25 1999 571-573
21. K.C. Sneeuw N.K. Aaronson J.R. Yarnold et al. Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessments Radiother Oncol 25 1992 153-159
22. J. Marinus C.G. Niel R.A. de Bie R.G. Wiggenraad E.M. Schoppink L.H. Beukema Measuring radiation fibrosis: The interobserver reliability of two methods of determining the degree of radiation fibrosis Int J Radiat Oncol Biol Phys 47 2000 1209-1217
23. A.M. Moody W.P. Mayles J.M. Bliss et al. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity Radiother Oncol 33 1994 106-112
24. I. Turesson J. Nyman E. Holmberg A. Oden Prognostic factors for acute and late skin reactions in radiotherapy patients Int J Radiat Oncol Biol Phys 36 1996 1065-1075
25. N.G. Burnet J. Nyman I. Turesson R. Wurm J.R. Yarnold J.H. Peacock Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity Lancet 339 1992 1570-1571
26. S.M. Bentzen J. Overgaard Patient-to-patient variability in the expression of radiation-induced normal tissue injury Semin Radiat Oncol 4 1994 68-80
27. J. Peacock A. Ashton J. Bliss et al. Cellular radiosensitivity and complication risk after curative radiotherapy Radiother Oncol 55 2000 173-178
28. C.N. Andreassen J. Alsner J. Overgaard Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? Radiother Oncol 64 2002 131-140
29. E. Van Limbergen A. Rijnders E. Van der Schueren et al. Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fraction schedules and surgical treatment techniques on cosmetic results Radiother Oncol 16 1989 253-267
30. C. Vrieling L. Collette A. et al. Fourquet The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost"; trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer Int J Radiat Oncol Biol Phys 45 1999 677-685
31. R.A. Cochrane P. Valasiadou A.R. Wilson S.K. Al-Ghazal R.D. Macmillan Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised Br J Surg 90 2003 1505-1509
32. M.E. Taylor C.A. Perez K.J. Halverson et al. Factors influencing cosmetic results after conservation therapy for breast cancer Int J Radiat Oncol Biol Phys 31 1995 753-764
33. B.A. Kramer D.W. Arthur K. Ulin R.K. Schmidt-Ullrich R.D. Zwicker D.E. Wazer Cosmetic outcome in patients receiving an interstitial implant as part of breast-conservation therapy Radiology 213 1999 61-66
34. J.A. Dewar S. Benhamou E. Benhamou et al. Cosmetic results following lumpectomy, axillary dissection and radiotherapy for small breast cancers Radiother Oncol 12 1988 273-280
35. D.E. Wazer R.K. Schmidt-Ullrich R. Ruthazer et al. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed Int J Radiat Oncol Biol Phys 40 1998 851-858
36. S.K. Cetintas L. Ozkan M. Kurt et al. Factors influencing cosmetic results after breast conserving management (Turkish experience) Breast 11 2002 72-80
37. D.E. Wazer T. DiPetrillo R. Schmidt-Ullrich et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma J Clin Oncol 10 1992 356-363
38. J.W. Hopewell J.L. Foster C.M. Young G. Wiernik Late radiation damage to pig skin Radiology 130 1979 783-788
39. H.R. Withers H.D. Thames Jr. D.H. Hussey B.L. Flow K.A. Mason Relative biological effectiveness (RBE) of 50 MV (Be) neutrons for acute and late skin injury Int J Radiat Oncol Biol Phys 4 1978 603-608
40. J.R. Harris M.B. Levene G. Svensson S. Hellman Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast Int J Radiat Oncol Biol Phys 5 1979 257-261
41. I.A. Olivotto L.M. Weir C. Kim-Sing Late cosmetic results of short fractionation for breast conservation Radiother Oncol 41 1996 7-13
42. W. Shelley M. Brundage C. Hayter L. Paszat S. Zhou W. Mackillop A shorter fractionation schedule for postlumpectomy breast cancer patients Int J Radiat Oncol Biol Phys 47 2000 1219-1228
43. D. Spooner et al. The role of radiotherapy in breast cancer (stage 1). A west Midlands Breast group prospective collaborative study (BR3002). Abstract of the 4th Nottingham International Breast Cancer Conference Breast 4 1995 231-232
44. J. Yarnold J.R. Owen A. Ashton et al. Fractionation sensitivity of change in breast appearance after radiotherapy for early breast cancer: long-term results of a randomised trial Clin Oncol 14 2002 S44
45. D.V. Ash E.A. Benson J.R. Sainsbury C. Round C. Head Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: A report of the Yorkshire Breast Cancer Group Clin Oncol 7 1995 93-96
46. T. Whelan R. MacKenzie J. Julian et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer J Natl Cancer Inst 94 2002 1143-1150
47. F. Meric T.A. Buchholz N.Q. Mirza et al. Long-term complications associated with breast-conservation surgery and radiotherapy Ann Surg Oncol 9 2002 543-549
48. J. Johansen J. Overgaard C. Rose et al. Cosmetic outcome and breast morbidity in breast-conserving treatment: Results from the Danish DBCG-82TM national randomized trial in breast cancer Acta Oncol 41 2002 369-380
49. H. Bartelink Commentary on the paper "A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated";. A critical review of an innovative approach Eur J Cancer 37 2001 2143-2146
50. Bowden S, Fernando I, Dunn J on behalf of the SECRAB Steering Committee (2001). The use of a pre-trial questionnaire in determining recruitment intent in a study of sequencing chemotherapy and radiotherapy. British Journal of Cancer. Abstract 11. See http://212.219.75.236/ukcccr/text_only/home.html
51. A.J. Neal M. Torr S. Helyer J.R. Yarnold Correlation of breast dose heterogeneity with breast size using 3D CT planning and dose-volume histograms Radiother Oncol 34 1995 210-218
52. G. Moro M. Stasi V.C. Borca Does concomitant chemoradiotherapy influence cosmetic outcome in conservative treatment of breast cancer? Tumori 83 1997 743-747
53. A.L. Abner A. Recht F.A. Vicini Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer Int J Radiat Oncol Biol Phys 21 1991 331-338
54. D.E. Wazer J. Morr J.K. Erban C.H. Schmid R. Ruthazer R.K. Schmidt-Ullrich The effects of postradiation treatment with tamoxifen on local control and cosmetic outcome in the conservatively treated breast Cancer 80 1997 732-740
55. D. Azria W. Jeanneret Sozzi A. Zouhair et al. Potentiation of radiation-induced subcutaneous fibrosis by concomitant use of tamoxifen in adjuvant breast cancer Breast Cancer Res Treat 82 2003 S183
56. J. Cuzick H. Stewart L. Rutqvist et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy J Clin Oncol 12 1994 447-453
57. I. Hojris M. Overgaard J.J. Christensen J. Overgaard Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group Lancet 354 1999 1425-1430
58. K.A. Vallis M. Pintilie N. Chong et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer J Clin Oncol 20 2002 1036-1042
59. S.A. Fuller J.L. Haybittle R.E. Smith H.J. Dobbs Cardiac doses in post-operative breast irradiation Radiother Oncol 25 1992 19-24
60. C.W. Hurkmans J.H. Borger L.J. Bos et al. Cardiac and lung complication probabilities after breast cancer irradiation Radiother Oncol 55 2000 145-151
61. G. Gagliardi I. Lax S. Soderstrom G. Gyenes L.E. Rutqvist Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer Radiother Oncol 46 1998 63-71
62. G. Gyenes T. Fornander P. Carlens U. Glas L.E. Rutqvist Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: A prospective study Int J Radiat Oncol Biol Phys 36 1996 899-905
63. P.H. Hardenbergh M.T. Munley G.C. Bentel et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: Preliminary results Int J Radiat Oncol Biol Phys 49 2001 1023-1028
64. B. Fisher S. Land E. Mamounas J. Dignam E.R. Fisher N. Wolmark Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience Semin Oncol 28 2001 400-418
65. N. Bijker J.L. Peterse L. Duchateau et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853 J Clin Oncol 19 2001 2263-2271
66. J.C. Theuws Y. Seppenwoolde S.L. Kwa et al. Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer Int J Radiat Oncol Biol Phys 47 2000 1201-1208
67. J.Z. Skoczylas S.M. Bentzen M. Overgaard J. Overgaard Time course of radiological lung density changes after postmastectomy radiotherapy Acta Oncol 39 2000 181-187
68. A.J. Neal J.R. Yarnold Estimating the volume of lung irradiated during tangential breast irradiation using the central lung distance Br J Radiol 68 1995 1004-1008
69. L.P. Muren G. Maurstad R. Hafslund G. Anker O. Dahl Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer Radiother Oncol 62 2002 173-183
70. P.A. Lind L.B. Marks P.H. Hardenbergh Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer Int J Radiat Oncol Biol Phys 52 2002 137-143
71. T.I. Lingos A. Recht F. Vicini A. Abner B. Silver J.R. Harris Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy Int J Radiat Oncol Biol Phys 21 1991 355-360
72. M. Overgaard M.B. Jenson J. Overgaard Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Co-operative Group DBCG 82c randomized trial Lancet 353 9165 1999 1641-1648